436 related articles for article (PubMed ID: 33646447)
21. Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?
Pereda CA; Nishishinya-Aquino MB; Brito-García N; Díaz Del Campo Fontecha P; Rua-Figueroa I
Rheumatol Int; 2021 Aug; 41(8):1419-1427. PubMed ID: 33656582
[TBL] [Abstract][Full Text] [Related]
22. High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis.
Chen X; Shu X; He L; Yang H; Lu X; Wang G; Ge Y
Rheumatology (Oxford); 2023 Oct; 62(10):3302-3309. PubMed ID: 36734589
[TBL] [Abstract][Full Text] [Related]
23. Association between autoimmune rheumatic diseases and the risk of dementia.
Lu K; Wang HK; Yeh CC; Huang CY; Sung PS; Wang LC; Muo CH; Sung FC; Chen HJ; Li YC; Chang LC; Tsai KJ
Biomed Res Int; 2014; 2014():861812. PubMed ID: 24877143
[TBL] [Abstract][Full Text] [Related]
24. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study.
See LC; Kuo CF; Chou IJ; Chiou MJ; Yu KH
Semin Arthritis Rheum; 2013 Dec; 43(3):381-6. PubMed ID: 23916348
[TBL] [Abstract][Full Text] [Related]
25. Risk Factors of
Yoon J; Hong SW; Han KD; Lee SW; Shin CM; Park YS; Kim N; Lee DH; Kim JS; Yoon H
Gut Liver; 2024 May; 18(3):489-497. PubMed ID: 37867439
[TBL] [Abstract][Full Text] [Related]
26. Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.
Zhang Y; Zheng Y
Rheumatol Int; 2014 Dec; 34(12):1765-71. PubMed ID: 24948376
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic effect of sulfasalazine against Pneumocystis pneumonia in patients with rheumatoid arthritis: A nested case-control study.
Nunokawa T; Yokogawa N; Shimada K; Sugii S; Nishino J; Gosho M; Wagatsuma Y; Tohma S
Semin Arthritis Rheum; 2019 Feb; 48(4):573-578. PubMed ID: 30057321
[TBL] [Abstract][Full Text] [Related]
28. Risk-Benefit Analysis of Primary Prophylaxis Against Pneumocystis Jirovecii Pneumonia in Patients With Rheumatic Diseases Receiving Rituximab.
Park JW; Curtis JR; Choi SR; Kim MJ; Ha YJ; Kang EH; Lee YJ; Lee EB
Arthritis Rheumatol; 2023 Nov; 75(11):2036-2044. PubMed ID: 37096489
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases.
Ghembaza A; Vautier M; Cacoub P; Pourcher V; Saadoun D
Chest; 2020 Dec; 158(6):2323-2332. PubMed ID: 32502592
[TBL] [Abstract][Full Text] [Related]
30. Characterization and associated risk factors of Pneumocystis jirovecii pneumonia in patients with AIRD: a retrospective study.
Zhao Z; Huang Y; Ming B; Zhong J; Dong L
Rheumatology (Oxford); 2022 Aug; 61(9):3766-3776. PubMed ID: 34962999
[TBL] [Abstract][Full Text] [Related]
31. [Pneumocystis jirovecii Pneumonia in Patients with Lung Cancer: A Review].
Li T; Zhou J; Wang Q
Zhongguo Fei Ai Za Zhi; 2022 Apr; 25(4):272-277. PubMed ID: 35340199
[TBL] [Abstract][Full Text] [Related]
32. Rapidly progressive interstitial lung disease combined with pneumocystis jiroveci pneumonia in a patient with single anti-TIF-1γ antibody positive dermatomyositis in the context of an underlying tumor.
Zhang H; Yue J; Hou X; Lu H; Bikdeli A; Guo H; Li H; Li D
BMC Pulm Med; 2023 Jul; 23(1):248. PubMed ID: 37415133
[TBL] [Abstract][Full Text] [Related]
33. Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.
Rice ML; Barreto JN; Thompson CA; Mara KC; Tosh PK; Limper AH
Cancer Med; 2021 Aug; 10(15):5120-5130. PubMed ID: 34155819
[TBL] [Abstract][Full Text] [Related]
34. Association of systemic and thyroid autoimmune diseases.
Biró E; Szekanecz Z; Czirják L; Dankó K; Kiss E; Szabó NA; Szucs G; Zeher M; Bodolay E; Szegedi G; Bakó G
Clin Rheumatol; 2006 Mar; 25(2):240-5. PubMed ID: 16247581
[TBL] [Abstract][Full Text] [Related]
35. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus.
Kadoya A; Okada J; Iikuni Y; Kondo H
J Rheumatol; 1996 Jul; 23(7):1186-8. PubMed ID: 8823690
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan.
Yu KH; See LC; Kuo CF; Chou IJ; Chou MJ
Arthritis Care Res (Hoboken); 2013 Feb; 65(2):244-50. PubMed ID: 22899470
[TBL] [Abstract][Full Text] [Related]
38. Pneumocystis jirovecii pneumonia in African miners at autopsy.
Wong ML; Back P; Candy G; Nelson G; Murray J
Int J Tuberc Lung Dis; 2006 Jul; 10(7):756-60. PubMed ID: 16848337
[TBL] [Abstract][Full Text] [Related]
39. Survival rates of cancer patients with and without rheumatic disease: a retrospective cohort analysis.
Park JK; Yang JA; Ahn EY; Chang SH; Song YW; Curtis JR; Lee EB
BMC Cancer; 2016 Jul; 16():381. PubMed ID: 27412038
[TBL] [Abstract][Full Text] [Related]
40. Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea.
Hsiao YH; Chen YT; Tseng CM; Wu LA; Lin WC; Su VY; Perng DW; Chang SC; Chen YM; Chen TJ; Lee YC; Chou KT
Sleep; 2015 Apr; 38(4):581-6. PubMed ID: 25669189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
